Literature DB >> 1768167

Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

R Hällgren1, B Gudbjörnsson, E Larsson, K Fredens.   

Abstract

The possible role of the eosinophil and its cytotoxic granule proteins in the vascular lesions seen in temporal arteritis was elucidated. Sixteen sections of biopsy specimens from arteria temporalis showing giant cell arteritis were stained for eosinophil cationic protein (ECP) by polyclonal antibodies and the immunoperoxidase method. Activated eosinophils were identified by monoclonal antibodies linked to alkaline phosphatase. Activated eosinophils and secreted ECP were seen in all layers of the inflamed vessels and were most evident in necrotic lesions and thrombi. Only a small number of granulocytes seen in the adventitia were immunoreactive for cathepsin G, and no extracellular deposits of this neutrophil granule protein were seen. A few immunoreactive eosinophils were found in the adventitia in two of five negative temporal artery biopsy specimens from patients with polymyalgia rheumatica. All eight coronary artery biopsy specimens with atherosclerotic lesions showed no activated eosinophils or secreted ECP. These findings indicate that eosinophils are involved in the vascular lesion in temporal arteritis and suggest that cytotoxic eosinophil granule proteins may contribute to the necrotic lesions and the development of thrombi.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768167      PMCID: PMC1004589          DOI: 10.1136/ard.50.12.946

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage.

Authors:  K Fredens; H Dybdahl; R Dahl; U Baandrup
Journal:  APMIS       Date:  1988-08       Impact factor: 3.205

2.  Role of inflammatory cells in Chagas' disease. III. Kinetics of human eosinophil activation upon interaction with parasites (Trypanosoma cruzi).

Authors:  F Kierszenbaum; F Villalta; P C Tai
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

4.  T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.

Authors:  R Andersson; R Jonsson; A Tarkowski; B A Bengtsson; B E Malmvall
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

5.  Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome.

Authors:  R Hällgren; T Samuelsson; P Venge; J Modig
Journal:  Am Rev Respir Dis       Date:  1987-03

6.  The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.

Authors:  R Hällgren; L Bjermer; R Lundgren; P Venge
Journal:  Am Rev Respir Dis       Date:  1989-02

7.  Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; Y Nawa
Journal:  Int Arch Allergy Appl Immunol       Date:  1987

8.  Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.

Authors:  P C Tai; S J Ackerman; C J Spry; S Dunnette; E G Olsen; G J Gleich
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

9.  Eosinophils and resistance to Trichinella spiralis.

Authors:  D I Grove; A A Mahmoud; K S Warren
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

10.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  2 in total

Review 1.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

2.  Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin.

Authors:  Cristina Almengló; Xiaoran Fu; María Teresa Flores-Arias; Ángel L Fernández; Juan E Viñuela; José M Martínez-Cereijo; Darío Durán; Moisés Rodríguez-Mañero; José R González-Juanatey; Sonia Eiras
Journal:  J Cell Mol Med       Date:  2022-07-11       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.